Cite

HARVARD Citation

    Babu, M. et al. (2021). Relugolix: A Novel Gonadotropin-Releasing Hormone Antagonist for Prostate Cancer. Journal of pharmacology and pharmacotherapeutics. 12 (1), pp. 26-28. [Online]. 
  
Back to record